FDA Recommends Federal Restrictions On Kratom Extract
By Sam Reisman · July 29, 2025, 7:31 PM EDT
The U.S. Food and Drug Administration announced Tuesday that it recommends placing federal restrictions on 7-Hydroxymitragynine, or 7-OH, an opioid-like alkaloid compound derived from the kratom leaf that the agency said...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login